The Advantages of Mesenchymal Stem Cell-Derived Extracellular Vesicles as Drug Delivery SystemsXiubin Kuang, Zhengqiang Yuan, Junsheng Peng et al.|Stem Cell Reviews and Reports|2025Cited by 3
Exosomal delivery of AZD5582 to overcome TRAIL resistance as an optimal therapy against triple-negative breast cancerWanting Zhang, Zhengqiang Yuan, Quanjiang Li et al.|Acta Histochemica|2025Cited by 2